First American Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $340K | Sell |
5,607
-215
| -4% | -$12.5K | 0.02% | 224 |
|
|
2025
Q4 | $314K | Buy |
+5,822
| New | +$280K | 0.02% | 231 |
|
|
2025
Q2 | – | Sell |
-4,077
| Closed | -$249K | – | 249 |
|
|
2025
Q1 | $249K | Sell |
4,077
-2,675
| -40% | -$156K | 0.02% | 203 |
|
|
2024
Q4 | $382K | Sell |
6,752
-91
| -1% | -$5.08K | 0.04% | 170 |
|
|
2024
Q3 | $354K | Sell |
6,843
-13
| -0.2% | -$610 | 0.04% | 170 |
|
|
2024
Q2 | $285K | Buy |
6,856
+589
| +9% | +$26.4K | 0.03% | 172 |
|
|
2024
Q1 | $340K | Buy |
+6,267
| New | +$319K | 0.04% | 165 |
|
|
2022
Q4 | – | Sell |
-2,875
| Closed | -$204K | – | 156 |
|
|
2022
Q3 | $204K | Sell |
2,875
-410
| -12% | -$29.7K | 0.03% | 147 |
|
|
2022
Q2 | $253K | Sell |
3,285
-25
| -0.8% | -$1.9K | 0.04% | 141 |
|
|
2022
Q1 | $242K | Buy |
3,310
+90
| +3% | +$6.04K | 0.03% | 147 |
|
|
2021
Q4 | $201K | Buy |
+3,220
| New | +$189K | 0.03% | 157 |
|
|
2021
Q3 | – | Sell |
-3,361
| Closed | -$225K | – | 157 |
|
|
2021
Q2 | $225K | Hold |
3,361
| – | – | 0.04% | 143 |
|
|
2021
Q1 | $212K | Hold |
3,361
| – | – | 0.03% | 145 |
|
|
2020
Q4 | $208K | Buy |
3,361
+14
| +0.4% | +$861 | 0.03% | 144 |
|
|
2020
Q3 | $202K | Buy |
+3,347
| New | +$201K | 0.04% | 136 |
|
|
2020
Q1 | – | Sell |
-3,160
| Closed | -$203K | – | 113 |
|
|
2019
Q4 | $203K | Buy |
+3,160
| New | +$181K | 0.04% | 138 |
|
|
2019
Q1 | – | Sell |
-4,663
| Closed | -$242K | – | 117 |
|
|
2018
Q4 | $242K | Sell |
4,663
-40,941
| -90% | -$2.2M | 0.06% | 97 |
|
|
2018
Q3 | $2.83M | Sell |
45,604
-38,861
| -46% | -$2.31M | 0.63% | 57 |
|
|
2018
Q2 | $4.67M | Sell |
84,465
-18,368
| -18% | -$992K | 1.1% | 28 |
|
|
2018
Q1 | $6.5M | Sell |
102,833
-20,064
| -16% | -$1.29M | 1.58% | 17 |
|
|
2017
Q4 | $7.53M | Buy |
122,897
+426
| +0.3% | +$26.6K | 1.85% | 16 |
|
|
2017
Q3 | $7.81M | Buy |
122,471
+19,851
| +19% | +$1.16M | 2.04% | 10 |
|
|
2017
Q2 | $5.72M | Sell |
102,620
-140
| -0.1% | -$7.62K | 1.59% | 16 |
|
|
2017
Q1 | $5.59M | Sell |
102,760
-1,156
| -1% | -$63.4K | 1.7% | 15 |
|
|
2016
Q4 | $6.07M | Buy |
103,916
+15,086
| +17% | +$825K | 1.88% | 13 |
|
|
2016
Q3 | $4.79M | Sell |
88,830
-17,802
| -17% | -$1.14M | 1.5% | 22 |
|
|
2016
Q2 | $7.84M | Buy |
106,632
+10,627
| +11% | +$751K | 2.77% | 1 |
|
|
2016
Q1 | $6.13M | Buy |
96,005
+21,797
| +29% | +$1.37M | 2.15% | 12 |
|
|
2015
Q4 | $5.11M | Sell |
74,208
-9,985
| -12% | -$660K | 1.88% | 16 |
|
|
2015
Q3 | $4.99M | Buy |
84,193
+48,666
| +137% | +$3.09M | 1.93% | 16 |
|
|
2015
Q2 | $2.36M | Buy |
+35,527
| New | +$2.34M | 0.88% | 53 |
|
|
2014
Q4 | – | Sell |
-6,271
| Closed | -$321K | – | 93 |
|
|
2014
Q3 | $321K | Buy |
6,271
+821
| +15% | +$41K | 0.12% | 80 |
|
|
2014
Q2 | $265K | Sell |
5,450
-61,508
| -92% | -$3.03M | 0.1% | 80 |
|
|
2014
Q1 | $3.48M | Buy |
66,958
+12,000
| +22% | +$639K | 1.3% | 35 |
|
|
2013
Q4 | $2.92M | Hold |
54,958
| – | – | 0.99% | 43 |
|
|
2013
Q3 | $2.54M | Buy |
54,958
+44,580
| +430% | +$1.96M | 0.91% | 47 |
|
|
2013
Q2 | $464K | Buy |
+10,378
| New | +$451K | 0.17% | 81 |
|
Other funds holding BMY
VCM
VPM
First American Trust's BMY Position: Q1 2026 in Review
First American Trust reduced its Bristol-Myers Squibb (BMY) stake by 3.7% in Q1 2026, selling an estimated $12.5K and leaving 5,607 shares worth $340K. The position accounts for 0.02% of the portfolio, ranked #224.
First American Trust first reported a position in BMY in Q2 2013 and has held it in 37 quarters since. The position peaked at $7.84M in Q2 2016. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- First American Trust held 5,607 shares of Bristol-Myers Squibb worth $340K as of Q1 2026.
- First American Trust sold 215 Bristol-Myers Squibb shares in Q1 2026, an estimated $12.5K.
- Bristol-Myers Squibb made up 0.02% of First American Trust's portfolio in Q1 2026, its #224 holding.
- First American Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 37 quarters since.
- First American Trust's Bristol-Myers Squibb position peaked at $7.84M in Q2 2016.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on First American Trust's 13F filing for Q1 2026, filed 12 May 2026.